Loading clinical trials...
Loading clinical trials...
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN Study)
Conditions
Interventions
Ivacaftor or elexacaftor/tezacaftor/ivacaftor
Locations
35
United States
The Children's Hospital Alabama, University of Alabama at Birmingham
Birmingham, Alabama, United States
Stanford University Medical Center
Palo Alto, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
University of Miami
Miami, Florida, United States
The Nemours Children's Clinic - Orlando
Orlando, Florida, United States
Start Date
November 18, 2020
Primary Completion Date
December 1, 2029
Completion Date
December 1, 2029
Last Updated
August 12, 2024
NCT02417740
NCT06616857
NCT07108153
NCT02740868
NCT07303621
NCT07274631
Lead Sponsor
Sonya Heltshe
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions